| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8612567f6e82c0cb48b5c8e8a442512e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2007-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4c30fabf0f56a96904d36acb2fac29d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30545eba03584b16ce7ca3125ede1869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f8651b20b7ef18487027c71f0657c7e |
| publicationDate |
2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2068894-B1 |
| titleOfInvention |
Use of cis-rhenium (iii) diadamantate compounds for potentiating the antitumoral activity of platinium complexes |
| abstract |
The present invention relates to pharmaceutical associations comprising, as active principles, a cytotoxic platinum complex and a cluster rhenium compound of formula (I) in which: X is chlorine or bromine; R is the residue of adamantanecarboxylic acid; L is H2O; CH3CN, DMPA, DMAA, DMSO or pyridine. Application: potentiation of the antitumoral activity of cytotoxic platinum complexes. |
| priorityDate |
2006-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |